Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Limited-Stage Small Cell Lung Cancer

Clinical trial NCT06784206 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06784206
Sponsor: Peking University Cancer Hospital & Institute
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer, Limited Stage Hyperfractionated Accelerated Radiotherapy Simultaneous Radiotherapy and Chemotherapy

Start date: 2025-02-01
Primary completion: 2026-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.